STOCK TITAN

Eagle Pharmaceuticals to Present at September Healthcare Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Eagle Pharmaceuticals, Inc. (EGRX) has announced that CEO Scott Tarriff and CFO Brian Cahill will present at two upcoming investor conferences. The first is the Morgan Stanley 19th Annual Global Healthcare Conference on September 14, 2021, at 2:00 p.m. ET, with a live webcast available here. The second conference is the 2021 Cantor Virtual Global Healthcare Conference on September 28, 2021, at 4:40 p.m. ET, with a live webcast available here.

Positive
  • None.
Negative
  • None.

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)-- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that Scott Tarriff, Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will present at two upcoming investor conferences as follows:

Conference:

Morgan Stanley 19th Annual Global Healthcare Conference

Date:

Tuesday, September 14, 2021

Time:

2:00 p.m. ET

Webcast:

https://morganstanley.webcasts.com/starthere.jsp?ei=1488970&tp_key=c1aabe315b

Conference:

2021 Cantor Virtual Global Healthcare Conference

Date:

Tuesday, September 28, 2021

Time:

4:40 p.m. ET

Webcast:

https://wsw.com/webcast/cantor12/egrx/2096220

The presentations will be webcast live at the aforementioned times, and archived for 30 days thereafter, via the Company’s website at www.eagleus.com, under the Investors section.

About Eagle Pharmaceuticals, Inc.

Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients’ lives. Eagle’s commercialized products include RYANODEX®, BENDEKA®, BELRAPZO®, and its oncology and CNS/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. Additional information is available on Eagle’s website at www.eagleus.com.

Investor Relations for Eagle Pharmaceuticals, Inc.:

Lisa M. Wilson

In-Site Communications, Inc.

T: 212-452-2793

E: lwilson@insitecony.com

Source: Eagle Pharmaceuticals, Inc.

FAQ

What upcoming conferences will Eagle Pharmaceuticals present at?

Eagle Pharmaceuticals will present at the Morgan Stanley 19th Annual Global Healthcare Conference on September 14, 2021, and the 2021 Cantor Virtual Global Healthcare Conference on September 28, 2021.

When is the Morgan Stanley 19th Annual Global Healthcare Conference?

The Morgan Stanley 19th Annual Global Healthcare Conference is scheduled for September 14, 2021, at 2:00 p.m. ET.

How can I watch the Eagle Pharmaceuticals conference presentations?

You can watch the presentations live on Eagle Pharmaceuticals' website or via the conference webcasts. Links for both are provided in the press release.

What time is the Cantor Virtual Global Healthcare Conference presentation?

Eagle Pharmaceuticals will present at the Cantor Virtual Global Healthcare Conference on September 28, 2021, at 4:40 p.m. ET.

Who will be presenting at the conferences for Eagle Pharmaceuticals?

Scott Tarriff, CEO, and Brian Cahill, CFO of Eagle Pharmaceuticals, will be presenting at the conferences.

EAGLE PHARMS INC

OTC:EGRX

EGRX Rankings

EGRX Latest News

EGRX Stock Data

26.56M
11.43M
12.02%
80.89%
2.71%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
WOODCLIFF LAKE